| Fasting-mimicking diet and hormone therapy induce breast cancer regression I Caffa, V Spagnolo, C Vernieri, F Valdemarin, P Becherini, M Wei, ... Nature 583 (7817), 620-624, 2020 | 229 | 2020 |
| BRAF (V600E) mutation analysis on liquid‐based cytology‐processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid … ED Rossi, M Martini, S Capodimonti, CP Lombardi, A Pontecorvi, ... Cancer cytopathology 121 (6), 291-297, 2013 | 133* | 2013 |
| Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas A Fusco, MC Zatelli, A Bianchi, V Cimino, L Tilaro, F Veltri, F Angelini, ... The Journal of Clinical Endocrinology & Metabolism 93 (7), 2746-2750, 2008 | 125 | 2008 |
| HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? F Bussu, M Sali, R Gallus, VG Vellone, GF Zannoni, R Autorino, ... British journal of cancer 108 (5), 1157-1162, 2013 | 121 | 2013 |
| Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix P Cattani, GF Zannoni, C Ricci, S D'Onghia, IN Trivellizzi, A Di Franco, ... Journal of Clinical Microbiology 47 (12), 3895-3901, 2009 | 121 | 2009 |
| Ureteral endometriosis: a systematic review of epidemiology, pathogenesis, diagnosis, treatment, risk of malignant transformation and fertility F Barra, C Scala, E Biscaldi, VG Vellone, M Ceccaroni, C Terrone, ... Human reproduction update 24 (6), 710-730, 2018 | 110 | 2018 |
| RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus P Cattani, A Siddu, S D'Onghia, S Marchetti, R Santangelo, VG Vellone, ... Journal of clinical microbiology 47 (7), 2136-2141, 2009 | 99 | 2009 |
| Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors, and DNA repair F Piacente, I Caffa, S Ravera, G Sociali, M Passalacqua, VG Vellone, ... Cancer research 77 (14), 3857-3869, 2017 | 98 | 2017 |
| Class III β‐tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer M De Donato, M Mariani, L Petrella, E Martinelli, GF Zannoni, V Vellone, ... Journal of cellular physiology 227 (3), 1034-1041, 2012 | 96 | 2012 |
| Report of Positive Placental Swabs for SARS-CoV-2 in an Asymptomatic Pregnant Woman with COVID-19 A Ferraiolo, F Barra, C Kratochwila, M Paudice, VG Vellone, E Godano, ... Medicina 56 (6), E306, 2020 | 91 | 2020 |
| Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer F Barra, G Evangelisti, L Ferro Desideri, S Di Domenico, D Ferraioli, ... Expert Opinion on Investigational Drugs 28 (2), 131-142, 2019 | 85 | 2019 |
| Ovarian cancer arising in endometrioid cysts: ultrasound findings AC Testa, D Timmerman, C Van Holsbeke, GF Zannoni, S Fransis, ... Ultrasound in obstetrics & gynecology 38 (1), 99-106, 2011 | 76 | 2011 |
| Gray‐scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size E Epstein, C Van Holsbeke, F Mascilini, A Måsbäck, P Kannisto, L Ameye, ... Ultrasound in obstetrics & gynecology 38 (5), 586-593, 2011 | 74 | 2011 |
| Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical study GF Zannoni, VG Vellone, V Arena, MG Prisco, G Scambia, A Carbone, ... Virchows Archiv 457, 27-34, 2010 | 74 | 2010 |
| Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model G Sociali, M Magnone, S Ravera, P Damonte, T Vigliarolo, M Von Holtey, ... The FASEB Journal 31 (7), 3138, 2017 | 73 | 2017 |
| Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects … L Miele, A Forgione, G La Torre, V Vero, C Cefalo, S Racco, VG Vellone, ... Translational Research 154 (4), 194-201, 2009 | 62 | 2009 |
| Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival A Ciucci, I De Stefano, VG Vellone, L Lisi, C Bottoni, G Scambia, ... PloS one 8 (3), e60145, 2013 | 61 | 2013 |
| The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer GF Zannoni, G Monterossi, I De Stefano, A Gargini, MG Salerno, I Farulla, ... Human pathology 44 (6), 1047-1054, 2013 | 60* | 2013 |
| Morphological effects of radiochemotherapy on cervical carcinoma: a morphological study of 50 cases of hysterectomy specimens after neoadjuvant treatment GF Zannoni, VG Vellone, A Carbone International journal of gynecological pathology 27 (2), 274-281, 2008 | 58 | 2008 |
| Advances in pharmacotherapy for treating endometriosis E Tafi, U Leone Roberti Maggiore, F Alessandri, S Bogliolo, B Gardella, ... Expert opinion on pharmacotherapy 16 (16), 2465-2483, 2015 | 53* | 2015 |
Ennio BiscaldiGalliera Hospital, Genova, ItalyVerified email at galliera.it
